---
title: CMIC HOLDINGS Co., Ltd. vs Proxima Clinical Research
slug_a: cmicgroup
slug_b: proximacro
site: cro
review_signal_gate: closed
canonical_path: /compare/cmicgroup/proximacro
generated_by: BioBM Editorial AI
---

# CMIC HOLDINGS Co., Ltd. vs Proxima Clinical Research

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

CMIC HOLDINGS Co., Ltd. (cmicgroup) is listed for both. CMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing.

Services: 11. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Proxima Clinical Research (proximacro) is listed for cro. Proxima Clinical Research provides integrated regulatory, clinical, and quality solutions for life science companies, with expertise across device and therapeutic development pathways including IDE, 510(k), IND, NDA, and BLA submissions.

Services: 8. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.